Compare IRMD & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRMD | OMDA |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2014 | 2025 |
| Metric | IRMD | OMDA |
|---|---|---|
| Price | $86.32 | $20.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $118.00 | $28.42 |
| AVG Volume (30 Days) | 95.6K | ★ 990.4K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | 16.67 | ★ 94.27 |
| EPS | ★ 0.86 | 0.04 |
| Revenue | $83,814,000.00 | ★ $260,210,000.00 |
| Revenue This Year | $9.85 | $30.17 |
| Revenue Next Year | $13.07 | $20.40 |
| P/E Ratio | ★ $99.45 | $520.50 |
| Revenue Growth | 14.43 | ★ 53.24 |
| 52 Week Low | $71.34 | $10.28 |
| 52 Week High | $107.90 | $26.92 |
| Indicator | IRMD | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 53.14 | 48.63 |
| Support Level | $85.00 | $18.74 |
| Resistance Level | $88.59 | $21.52 |
| Average True Range (ATR) | 2.22 | 0.93 |
| MACD | 0.34 | 0.16 |
| Stochastic Oscillator | 76.78 | 73.59 |
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.